Olivia S. Kates

1.4k total citations
41 papers, 465 citations indexed

About

Olivia S. Kates is a scholar working on Infectious Diseases, Epidemiology and General Health Professions. According to data from OpenAlex, Olivia S. Kates has authored 41 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Infectious Diseases, 10 papers in Epidemiology and 9 papers in General Health Professions. Recurrent topics in Olivia S. Kates's work include COVID-19 Clinical Research Studies (7 papers), SARS-CoV-2 and COVID-19 Research (6 papers) and COVID-19 Impact on Reproduction (6 papers). Olivia S. Kates is often cited by papers focused on COVID-19 Clinical Research Studies (7 papers), SARS-CoV-2 and COVID-19 Research (6 papers) and COVID-19 Impact on Reproduction (6 papers). Olivia S. Kates collaborates with scholars based in United States, Thailand and Australia. Olivia S. Kates's co-authors include Stephen L. Kates, Daniel Ari Mendelson, Robert M. Rakita, Ajit P. Limaye, Cynthia E. Fisher, Susan M. Friedman, Jorgé Reyes, Madeleine R. Heldman, Erika D. Lease and Francis X. Riedo and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Clinical Infectious Diseases.

In The Last Decade

Olivia S. Kates

34 papers receiving 458 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olivia S. Kates United States 11 267 119 100 92 59 41 465
Michael Jahn Germany 9 425 1.6× 38 0.3× 65 0.7× 52 0.6× 46 0.8× 29 571
Teresa A. Hammett United States 8 261 1.0× 175 1.5× 41 0.4× 111 1.2× 26 0.4× 17 556
Yvon Ruch France 9 193 0.7× 50 0.4× 130 1.3× 98 1.1× 66 1.1× 31 439
Roshni Mathew United States 9 435 1.6× 284 2.4× 117 1.2× 87 0.9× 104 1.8× 19 728
Cristina Epalza Spain 11 374 1.4× 110 0.9× 127 1.3× 231 2.5× 62 1.1× 40 624
Ángel Paternina‐Caicedo Colombia 15 167 0.6× 90 0.8× 61 0.6× 114 1.2× 78 1.3× 73 598
Aimei Xia China 9 628 2.4× 89 0.7× 181 1.8× 135 1.5× 113 1.9× 16 826
Jordan L. Kennedy United States 8 114 0.4× 184 1.5× 41 0.4× 151 1.6× 15 0.3× 17 480
Mubbasheer Ahmed United States 6 220 0.8× 286 2.4× 85 0.8× 56 0.6× 58 1.0× 12 532
Kai‐Qian Kam Singapore 11 418 1.6× 65 0.5× 109 1.1× 132 1.4× 53 0.9× 31 645

Countries citing papers authored by Olivia S. Kates

Since Specialization
Citations

This map shows the geographic impact of Olivia S. Kates's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olivia S. Kates with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olivia S. Kates more than expected).

Fields of papers citing papers by Olivia S. Kates

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olivia S. Kates. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olivia S. Kates. The network helps show where Olivia S. Kates may publish in the future.

Co-authorship network of co-authors of Olivia S. Kates

This figure shows the co-authorship network connecting the top 25 collaborators of Olivia S. Kates. A scholar is included among the top collaborators of Olivia S. Kates based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olivia S. Kates. Olivia S. Kates is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Avery, Robin K., et al.. (2025). Optimizing IVIg in Xenotransplantation: A Call to Action. Transplantation. 1 indexed citations
2.
Barnes, Ashley, et al.. (2025). Fatal Donor-Derived KSHV Inflammatory Cytokine Syndrome (KICS) in Lung Transplant. The Journal of Heart and Lung Transplantation. 44(4). S309–S309.
3.
Kronenberg, Amy, Elizabeth W. Tucker, Martin A. Lodge, et al.. (2025). 18F-Fluorodeoxysorbitol PET for noninvasive detection of invasive mold infections: preclinical and first-in-human studies. Nature Communications. 16(1). 6395–6395. 1 indexed citations
4.
Furukawa, Daisuke, et al.. (2024). State-of-the-Art Review: Use of Antimicrobials at the End of Life. Clinical Infectious Diseases. 78(3). e27–e36. 9 indexed citations
5.
Kim, Ellie, Sarah E. Van Pilsum Rasmussen, Morgan Johnson, et al.. (2024). Patient Perspectives on Solid Organ Transplantation From Donors With Hepatitis C Viremia to Recipients Without Hepatitis C Viremia. Open Forum Infectious Diseases. 11(3). 1 indexed citations
6.
7.
Durand, Christine M., Hannah C. Sung, Olivia S. Kates, et al.. (2024). Building a successful transplant research center: Blueprints and barriers. Transplant Infectious Disease. 26(6). e14373–e14373. 1 indexed citations
8.
Kates, Olivia S., et al.. (2024). A Brief History of Antimicrobial Resistance. The AMA Journal of Ethic. 26(5). E408–417. 5 indexed citations
9.
Kates, Olivia S., et al.. (2023). Outcomes, Attitudes, and Updated Ethical Analysis of Early Liver Transplantation for Severe Alcoholic Hepatitis. Current Transplantation Reports. 10(4). 167–172. 1 indexed citations
10.
Manothummetha, Kasama, Anawin Sanguankeo, Pattama Torvorapanit, et al.. (2023). Ribavirin treatment for respiratory syncytial virus infection in patients with haematologic malignancy and haematopoietic stem cell transplant recipients: a systematic review and meta-analysis. Clinical Microbiology and Infection. 29(10). 1272–1279. 19 indexed citations
11.
Manothummetha, Kasama, Anawin Sanguankeo, Pattama Torvorapanit, et al.. (2023). Attenuated immunogenicity of SARS-CoV-2 vaccines and risk factors in stem cell transplant recipients: a meta-analysis. Blood Advances. 7(18). 5624–5636. 4 indexed citations
12.
Parent, Brendan, Olivia S. Kates, Wadih Arap, et al.. (2023). Research involving the recently deceased: ethics questions that must be answered. Journal of Medical Ethics. 50(9). 622–625. 2 indexed citations
13.
Manothummetha, Kasama, Anawin Sanguankeo, Morgan Walker, et al.. (2023). Prevalence of Ocular Candidiasis and Candida Endophthalmitis in Patients With Candidemia: A Systematic Review and Meta-Analysis. Clinical Infectious Diseases. 76(10). 1738–1749. 24 indexed citations
14.
Krantz, Elizabeth M., et al.. (2022). Antibiotic prescribing knowledge: A brief survey of providers and staff at an ambulatory cancer center during Antibiotic Awareness Week 2019. SHILAP Revista de lepidopterología. 2(1). e18–e18. 1 indexed citations
15.
Kates, Olivia S.. (2022). Approaches to pretransplant vaccination. Current Opinion in Organ Transplantation. 27(4). 277–284.
16.
Kates, Olivia S., Peter G. Stock, Michael G. Ison, et al.. (2021). Ethical review of COVID-19 vaccination requirements for transplant center staff and patients. American Journal of Transplantation. 22(2). 371–380. 29 indexed citations
17.
Heldman, Madeleine R. & Olivia S. Kates. (2021). COVID-19 in Solid Organ Transplant Recipients: a Review of the Current Literature. Current treatment options in infectious diseases. 13(3). 67–82. 16 indexed citations
18.
Cravedi, Paolo, Jesse D. Schold, Kassem Safa, et al.. (2020). The COVID‐19 pandemic: A community approach. Clinical Transplantation. 34(11). e14059–e14059. 8 indexed citations
19.
Kates, Olivia S., Cynthia E. Fisher, Helen C. Stankiewicz Karita, et al.. (2020). Earliest cases of coronavirus disease 2019 (COVID-19) identified in solid organ transplant recipients in the United States. American Journal of Transplantation. 20(7). 1885–1890. 71 indexed citations
20.
Kates, Stephen L., Olivia S. Kates, & Daniel Ari Mendelson. (2007). Advances in the medical management of osteoporosis. Injury. 38(3). 17–23. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael Jahn Breakdown of academic impact, for papers by Teresa A. Hammett Breakdown of academic impact, for papers by Yvon Ruch Breakdown of academic impact, for papers by Roshni Mathew Breakdown of academic impact, for papers by Cristina Epalza Breakdown of academic impact, for papers by Ángel Paternina‐Caicedo Breakdown of academic impact, for papers by Aimei Xia Breakdown of academic impact, for papers by Jordan L. Kennedy Breakdown of academic impact, for papers by Mubbasheer Ahmed Breakdown of academic impact, for papers by Kai‐Qian Kam
Rankless by CCL
2026